Six Dean Omar Branham Shirley Attorneys Honored for Representation of Plaintiffs
Dean Omar Branham Shirley, LLP announces six of its attorneys have been named to Lawdragon's 500 Leading Plaintiff Consumer Lawyers for 2025. Notable achievements include Jessica Dean's $45 million mesothelioma verdict against Johnson & Johnson (NYSE: JNJ) and Kenvue Inc. Partner Ben Braly secured a $22.5 million verdict against R.T. Vanderbilt in an asbestos-related case, while Mark Linder contributed to a groundbreaking $39 million verdict in a talc pleurodesis case in Massachusetts.
The honored attorneys include Jessica Dean (5th year), Amin Omar (4th year), Trey Branham, Lisa Shirley, Ben Braly, and Mark Linder. The firm reported securing at least six multimillion-dollar judgments for plaintiffs in 2024.
Dean Omar Branham Shirley, LLP annuncia che sei dei suoi avvocati sono stati nominati tra i 500 Migliori Avvocati di Diritto dei Consumatori per i Richiedenti da Lawdragon per il 2025. Tra i risultati notevoli c'è il verdetto di $45 milioni di Jessica Dean contro Johnson & Johnson (NYSE: JNJ) e Kenvue Inc. Il partner Ben Braly ha ottenuto un verdetto di $22,5 milioni contro R.T. Vanderbilt in un caso legato all'amianto, mentre Mark Linder ha contribuito a un verdetto innovativo di $39 milioni in un caso di pleurodesi da talco nel Massachusetts.
Gli avvocati onorati includono Jessica Dean (5° anno), Amin Omar (4° anno), Trey Branham, Lisa Shirley, Ben Braly e Mark Linder. Lo studio ha riportato di aver ottenuto almeno sei sentenze multimilionarie a favore dei richiedenti nel 2024.
Dean Omar Branham Shirley, LLP anuncia que seis de sus abogados han sido nombrados entre los 500 Mejores Abogados de Demandantes en Derecho del Consumidor por Lawdragon para 2025. Entre los logros notables se encuentra el veredicto de $45 millones de Jessica Dean contra Johnson & Johnson (NYSE: JNJ) y Kenvue Inc. El socio Ben Braly aseguró un veredicto de $22.5 millones contra R.T. Vanderbilt en un caso relacionado con el asbesto, mientras que Mark Linder contribuyó a un veredicto innovador de $39 millones en un caso de pleurodesis de talco en Massachusetts.
Los abogados honrados incluyen a Jessica Dean (5º año), Amin Omar (4º año), Trey Branham, Lisa Shirley, Ben Braly y Mark Linder. La firma informó que logró al menos seis juicios multimillonarios a favor de los demandantes en 2024.
딘 오마르 브랜햄 셔리 LLP는 2025년 로우드래곤의 500대 소비자 소송 변호사로 선정된 6명의 변호사를 발표했습니다. 주목할 만한 성과로는 제시카 딘이 존슨앤드존슨 (NYSE: JNJ)와 켄뷰 주식회사를 상대로 이긴 4,500만 달러의 석면 관련 판결이 있으며, 파트너 벤 브래리도 R.T. 밴더빌트에 대해 2,250만 달러의 판결을 확보했습니다. 마크 린더는 매사추세츠에서의 탈크 흉막유착 사례에서 3,900만 달러의 획기적인 판결에 기여했습니다.
수상한 변호사들은 제시카 딘(5년차), 아민 오마르(4년차), 트레이 브랜햄, 리사 셔리, 벤 브래리, 마크 린더입니다. 이 법무법인은 2024년 동안 원고를 위해 최소 6건의 수백만 달러 규모의 판결을 확보했다고 보고했습니다.
Dean Omar Branham Shirley, LLP annonce que six de ses avocats ont été nommés parmi les 500 Meilleurs Avocats Plaideurs en Droit des Consommateurs par Lawdragon pour 2025. Parmi les réalisations notables, on trouve le verdict de 45 millions de dollars de Jessica Dean contre Johnson & Johnson (NYSE: JNJ) et Kenvue Inc. Le partenaire Ben Braly a obtenu un verdict de 22,5 millions de dollars contre R.T. Vanderbilt dans une affaire liée à l'amiante, tandis que Mark Linder a contribué à un verdict révolutionnaire de 39 millions de dollars dans une affaire de pleurodèse au talc dans le Massachusetts.
Les avocats honorés incluent Jessica Dean (5e année), Amin Omar (4e année), Trey Branham, Lisa Shirley, Ben Braly et Mark Linder. Le cabinet a rapporté avoir obtenu au moins six jugements multimillionnaires pour les plaignants en 2024.
Dean Omar Branham Shirley, LLP gibt bekannt, dass sechs seiner Anwälte zu den 500 führenden Klägeranwälten für Verbraucher von Lawdragon für 2025 ernannt wurden. Zu den bemerkenswerten Erfolgen gehört das Urteil von Jessica Dean über 45 Millionen Dollar gegen Johnson & Johnson (NYSE: JNJ) und Kenvue Inc. Partner Ben Braly sicherte sich ein Urteil von 22,5 Millionen Dollar gegen R.T. Vanderbilt in einem asbestbezogenen Fall, während Mark Linder zu einem bahnbrechenden Urteil von 39 Millionen Dollar in einem Talkum-Pleurodese-Fall in Massachusetts beitrug.
Die ausgezeichneten Anwälte sind Jessica Dean (5. Jahr), Amin Omar (4. Jahr), Trey Branham, Lisa Shirley, Ben Braly und Mark Linder. Die Kanzlei berichtete, dass sie 2024 mindestens sechs Urteile in Millionenhöhe für Kläger gesichert hat.
- Multiple significant legal victories against major corporations, including a $45M verdict against JNJ
- Track record of securing multimillion-dollar judgments (at least 6 in 2024)
- Successful verdicts in different jurisdictions and case types, demonstrating broad litigation capabilities
- Legal victories against JNJ may impact future company financials and shareholder value
- Multiple large verdicts suggest ongoing liability risks for JNJ in similar cases
Insights
The $45 million mesothelioma verdict against Johnson & Johnson represents another significant legal setback in the company's ongoing talc litigation saga. This verdict, secured by Jessica Dean against both J&J and its consumer health spinoff Kenvue, adds to the mounting financial pressure from talc-related claims.
What's particularly concerning is the continued success this law firm is having against major corporations in asbestos litigation. The article notes they secured at least six multimillion-dollar judgments in 2024 alone, including a $39 million verdict in a first-of-its-kind talc pleurodesis case. While not all these verdicts target J&J specifically, they demonstrate the increasing effectiveness of plaintiff attorneys in these matters.
The mention of "important legal precedents for mesothelioma victims" established through the firm's appellate practice suggests these cases are strengthening the legal foundation for future claims. Each successful verdict potentially makes subsequent cases stronger by establishing liability precedents.
For context, J&J has been attempting to resolve its talc liabilities through a controversial Texas Two-Step bankruptcy strategy, which has faced significant judicial resistance. This continued stream of substantial verdicts suggests the litigation environment remains highly challenging despite these efforts. The
This legal development represents a modest but meaningful financial headwind for Johnson & Johnson. While a
J&J's talc litigation exposure remains one of the key risk factors in its financial profile. After multiple failed attempts to resolve these liabilities through bankruptcy proceedings of a subsidiary, the company continues to face case-by-case litigation with unpredictable outcomes. The latest verdict demonstrates that plaintiffs' attorneys are becoming increasingly effective in securing substantial judgments.
The spinoff of Kenvue was partially designed to separate consumer health products (including talc-based ones) from J&J's pharmaceutical and medical device businesses. However, this verdict shows that J&J remains liable for historical claims despite the separation. The mention of Kenvue as a co-defendant confirms that the corporate restructuring hasn't fully isolated these liabilities.
While J&J maintains strong cash reserves and can absorb individual verdicts of this magnitude, the cumulative impact of multiple verdicts combined with legal defense costs creates a persistent drain on resources that could otherwise be directed toward R&D or shareholder returns. The emergence of new types of cases (like the talc pleurodesis case mentioned) suggests the litigation scope may be expanding rather than contracting, potentially increasing the difficulty of quantifying the total expected liability.
Lawdragon names firm lawyers to 500 Leading Plaintiff Consumer Lawyers list
The annual listing describes this year’s honorees as “coast-to-coast champions who dedicate their lives to helping people going through the hardest moments of their lives.”
“A special thank you to Lawdragon for including us,” said Mr. Branham, the firm’s managing partner. “Our clients go through the most horrific circumstances, and we are honored to be their advocates.”
Ms. Dean celebrates her fifth year on the list. Last year she secured a
Mr. Omar, who is honored for a fourth year, is known for holding large corporations accountable for lapses in safety and for completing successful negotiations. He was cited for excellence in personal injury, product liability and workplace safety.
Mr. Branham, who was recognized for product liability and personal injury work, has spent decades representing plaintiffs in cases against some of the largest corporations in the nation.
Ms. Shirley heads the firm’s motion and appellate practice, and her work has led to important legal precedents for mesothelioma victims. Ms. Shirley is honored for asbestos, appellate, product liability and personal injury expertise.
Mr. Braly, honored for his asbestos, mesothelioma and product liability practice, secured multiple high-dollar verdicts in 2024, including a
Mr. Linder recently joined the firm. His practice involves toxic tort, product liability, personal injury litigation and appellate matters. He was recently involved in the first-ever verdict in a talc pleurodesis case in
In 2024, the firm secured at least a half-dozen multimillion-dollar judgments for plaintiffs.
Honorees for Lawdragon’s 500 Leading Plaintiff Consumer Lawyers are selected through journalistic reporting and research. View the full list here.
About Dean Omar Branham Shirley
Dean Omar Branham Shirley, LLP, is a nationally recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of irresponsible conduct of others. For more information, please visit http://www.dobslegal.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250310833863/en/
BeLynn Hollers
800-559-4534
belynn@androvett.com
Source: Dean Omar Branham Shirley, LLP
FAQ
What was the verdict amount in the Johnson & Johnson (JNJ) mesothelioma case won by Jessica Dean?
How many multimillion-dollar judgments did Dean Omar Branham Shirley secure in 2024?
What was the verdict amount in the talc pleurodesis case against JNJ in Massachusetts?
How much was the verdict against R.T. Vanderbilt in the asbestos-related wrongful death suit?
